RESP

Respiratory Disorders
Respiratory Changes Associated with Aging
  • Factors contributing to respiratory changes:

    • Heredity: Genetic predisposition can influence respiratory function and disease susceptibility.

    • Lifetime exposure to environmental pollutants: Exposure to pollutants such as smoke, dust, and chemical fumes can lead to chronic lung diseases.

    • Total body decrease in water content: This impacts mucosal hydration in the airways, making it harder to clear secretions.

    • Impairment of ciliary action: Aging can lead to reduced ciliary function that is critical for trapping and clearing particles from the lungs.

    • Decreased strength for cough: Weaker respiratory muscles result in less effective coughing, increasing infection risk.

    • Increased rigidity of the chest wall: Stiffening of the chest wall can lead to reduced lung expansion and decreased tidal volume.

Assessment Indicators
  • Key observations for respiratory distress:

    • Dyspnea (difficulty breathing): Can be assessed by observing the patient’s breathing patterns and their ability to speak in full sentences.

    • Nasal flaring: A sign of respiratory distress, especially in pediatric patients.

    • Use of accessory muscles for breathing: Indicates increased work of breathing, often seen in conditions like asthma or COPD.

    • Pursed-lip breathing or diaphragmatic breathing: Techniques patients might use to increase airflow during respiratory distress.

    • Decreased endurance: Fatigue during physical activity results from impaired respiratory function.

    • Changes in skin and mucous membranes: Signs such as pallor can indicate inadequate oxygen supply, while cyanosis suggests significant hypoxia.

Chest Structure and Function
  • Normal vs. Abnormal Chest Shapes:

    • Normal chest wall: Characteristics include a symmetric shape with the anteroposterior diameter smaller than the transverse diameter (ratio approximately 1:2).

    • Barrel chest: Increased anterior-posterior diameter associated with conditions like emphysema due to chronic air trapping.

Gas Exchange
  • Importance of effective gas exchange is critical for maintaining oxygen balance in the body. Impaired gas exchange can lead to serious complications, including hypoxia and respiratory acidosis.

Diagnostic Tests
  • Common diagnostic tests for respiratory assessment:

    • X-ray: Provides anterior-posterior (A/P) and lateral views to assess lung structure, identify infections, or confirm abnormalities like consolidation.

    • Lung Ventilation and Perfusion Scan (VQ Scan): Evaluates the relationship between ventilation and perfusion, helping to identify conditions such as pulmonary embolism.

    • Bronchoscopy: Allows direct visualization of the airways and may facilitate biopsy; pre-procedure requirements include obtaining consent, monitoring vital signs, ensuring gag reflex integrity, providing mild sedation, and maintaining NPO status.

    • Post-procedure monitoring: Watch for complications like pink mucous, coughing up blood, or laryngeal spasm that could lead to respiratory distress.

    • Hemoglobin (HGB) levels: Important for oxygen transport; low HGB levels can lead to fatigue and shortness of breath (SOB).

    • D-Dimer Test: Detects elevated fibrin, indicating clotting activity; a normal result suggests no blood clot, although it does not provide a diagnosis.

    • Arterial Blood Gas (ABGs): Assessed via blood from the radial artery; Allen's test is used to confirm adequate wrist circulation prior to sampling.

    • Thoracentesis: Procedure to remove fluid from the pleural space for diagnostic or therapeutic purposes, requiring both consent and sedation.

    • Pulmonary Angiography and Pulmonary Function Testing: Aid in understanding airflow and lung function.

    • Oxygen Saturation Measurement: Essential for monitoring blood oxygen levels with pulse oximetry.

Understanding Ventilation vs. Perfusion
  • Ventilation: Refers to the movement of air into and out of the lungs. It requires intact airway patency and functional lung parenchyma.

  • Perfusion: Describes the blood flow to the alveoli for gas exchange. Adequate perfusion is crucial for effective oxygenation and carbon dioxide elimination.

  • Differentiating between these two processes: Understanding the distinction is vital for appropriate patient management and improving outcomes in respiratory diseases.

Therapeutic Measures for Respiratory Issues
  • Management Techniques:

    • Humidification: Used to moisten airways and make secretions easier to manage. Important in oxygen therapy to prevent drying out mucosa.

    • Pulmonary hygiene practices: Techniques such as chest physiotherapy enhance airway clearance and can improve lung function.

    • Oxygen therapy: Must be tailored to individual patient needs, adjusting flow rates as required based on oxygen saturation levels.

Care for Patients with Respiratory Stressors

Pneumonia

  • Types: Classified as either bacterial or viral; causes vary, and understanding the type informs treatment.

  • Signs and Symptoms:

    • Fever: Often presents with chills, indicating systemic infection.

    • Dyspnea: Difficulty breathing may vary from mild to severe, affecting daily activities.

    • Sputum production: Notable sputum colors include yellow or green, signaling possible bacterial infection.

  • Diagnostic Tests:

    • Chest X-ray: Determines presence of consolidation or infiltrate.

    • Sputum analysis: Used for pathogen identification to tailor antibiotic therapy.

  • Medical Treatment:

    • Antibiotics: Side effects may include nausea, vomiting, diarrhea (N/V/D), alongside risks such as thrush or C. difficile infections.

    • Laboratory Monitoring: Critical to monitor kidney function, especially with nephrotoxic antibiotics, requiring daily assessment of BUN, creatinine, and GFR.

Ototoxicity

  • Effects include: Hearing loss, tinnitus (ringing in ears), which may result from certain medications, impacting overall well-being.

Drug Concentration Monitoring

  • Peaks and Troughs:

    • Peak Concentration: Indicates the maximum level of a drug in the bloodstream post-administration and is used to measure therapeutic effects.

    • Trough Concentration: Assessed to ensure the drug does not reach toxic levels, typically drawn 30 minutes before the next scheduled dose.

Commonly Used Medications

  • Vancomycin Levels: The target therapeutic range is between 10-20 mg/L; monitor closely to avoid toxicity.

  • Antipyretics: Medications such as Acetaminophen (Tylenol) and Ibuprofen, the latter should be monitored for potential renal side effects when used with nephrotoxic antibiotics.

Expectorants

  • Guaifenesin: Promotes mucus clearance from airways; hydration is key for optimal effectiveness as water is a natural expectorant.

Respiratory Treatments

  • Albuterol: As a rescue inhaler, it provides rapid bronchodilation through beta-2 adrenergic stimulation; caution for side effects such as increased heart rate and tremors.

  • Duoneb (Nebulized Therapy): Combines beta-agonists and anticholinergics for enhanced bronchodilation effects.

  • Adrenergic Agonists: Medications that activate the sympathetic nervous system to induce bronchodilation, supporting respiratory function in crisis scenarios.

Nursing Interventions for Respiratory Care
  • Key Interventions:

    • Adequate rest: Essential for recovery and effective healing from respiratory distress.

    • Encouraging fluid intake: Helps thin secretions, making them easier to clear; monitoring hydration status is critical.

    • Coughing and deep breathing exercises (C&DB): Teach patients these techniques to enhance lung expansion and secretion clearance.

    • Nutrition management: Advise on high-protein, calorie-dense foods in small frequent meals to support overall health and recovery.

    • Avoidance of milky and caffeinated products: These can thicken secretions, complicating respiratory issues.

Pleurisy

  • Definition: Inflammation of the pleura, which can cause sharp, pleuritic chest pain.

  • Symptoms: Typically pain worsens with deep breathing; may be accompanied by other systemic symptoms.

  • Medical Treatment: Usually involves NSAIDs such as ibuprofen for pain management.

Empyema

  • Definition: Infection of the pleural cavity leading to accumulation of purulent fluid; often requires drainage.

  • Diagnostic Test: Assess pleural fluid characteristics, often identified as thick and purulent.

  • Medical Treatment: Includes antibiotics with supportive therapies like chest tube drainage.

Chronic Respiratory Conditions

Chronic Obstructive Pulmonary Disease (COPD) or Chronic Asthma-Like Disease (CAL)

  • Conditions Include:

    • Pulmonary Emphysema: Characterized by irreversible damage to terminal air sacs, leading to air trapping and reduced gas exchange.

      • Diagnostic Tests: May reveal respiratory acidosis on ABGs and confirm diagnosis through pulmonary function tests (PFTs).

      • Symptoms: Patients may present with a thin body type, barrel chest, elevated diaphragm, chronic dyspnea, and digital clubbing.

    • Chronic Bronchitis: Defined by inflammation of the bronchi, attributed to recurrent infections and irritants.

      • Diagnostic Tests: A persistent cough lasting three months of each year for two consecutive years is a typical diagnostic criterion along with ABGs and hematocrit levels.

      • Symptoms: Presents with productive cough, shortness of breath, ruddy skin, and increased chest diameter.

      • Medical Management: Involves bronchodilators (e.g., beta-agonists) and corticosteroids.

      • Combination Therapy: Consideration of dual or triple therapy involving various respiratory medications for optimized control.

Tuberculosis (TB)

  • Opportunistic vs. Contagious Nature: TB is particularly dangerous in immunocompromised individuals, necessitating vigilant screening.

  • Signs and Symptoms: Includes chronic cough, hemoptysis, low-grade afternoon fevers, weight loss, and night sweats.

  • Diagnostic Tests: Utilize PPD skin tests, chest X-rays, and sputum AFB tests for confirmation.

  • Medical Treatment: Common regimen includes isoniazid and rifampin over an extended course for effective management.

Chest Injury/Pneumothorax

  • Signs and Symptoms: Characterized by sudden shortness of breath and potential absent breath sounds on affected side.

  • Diagnostic Test: A chest X-ray (CXR) is primarily used to confirm the presence of pneumothorax.

  • Medical Treatment:

    • Minor Cases: May resolve without intervention but need regular reassessment.

    • Major Cases: Chest tube placement may be necessary for re-expansion of the lung to restore normal function.

Nursing Interventions for Pneumothorax

  • Monitoring vital signs and assessing for complications, paying special attention to excessive drainage (>100 mL/hour), subcutaneous emphysema, and persistent bubbling in drainage tubes.

Pulmonary Embolism (PE)

  • Risk Factors: Include prolonged immobilization, central venous catheters, obesity, advanced age, previous thromboembolic events, and contraceptive pill use.

  • Symptoms: Patients may experience sudden dyspnea, chest pain, cough, hemoptysis, apprehension, and a rapid decline in oxygen saturation levels.

  • Diagnostics: D-dimer levels assess clotting, and if elevated, CT or VQ scans may be employed for direct imaging.

Planning and Implementation for PE
  • Oxygen Therapy Options: Nasal cannula or mask application based on oxygen saturation goals, continuous monitoring of pulse oximetry is necessary for assessing treatment efficacy.

  • Drug Therapy: Involves initiation of anticoagulants and, in some cases, thrombolytics to effectively manage clotting and prevent further embolism.